
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Finasteride | FAERS: 13 | US FAERS | |
| 2 | Isotretinoin | FAERS: 4 | US FAERS | |
| 3 | 4-hydroxybutyric acid | FAERS: 2 | US FAERS | |
| 4 | rofecoxib | FAERS: 2 | OFFSIDES US FAERS | |
| 5 | Celecoxib | FAERS: 1 | US FAERS | |
| 6 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 7 | Teriparatide | FAERS: 1 | US FAERS | |
| 8 | Tolterodine Tartrate | FAERS: 1 | US FAERS | |
| 9 | etonogestrel | FAERS: 1 | US FAERS | |
| 10 | Dasatinib | OFFSIDES | ||
| 11 | Dutasteride | OFFSIDES | ||
| 12 | Goserelin | OFFSIDES | ||
| 13 | Ketoconazole | OFFSIDES | ||
| 14 | Medroxyprogesterone Acetate | OFFSIDES | ||
| 15 | Medroxyprogesterone | OFFSIDES | ||
| 16 | Tretinoin | OFFSIDES | ||
| 17 | Ubiquinone | OFFSIDES | ||
| 18 | Zoledronic Acid | OFFSIDES | ||
| 19 | bicalutamide | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.